# Efficacy and Adverse Effects of Prapchompoothaweep Remedy and Loratadine for Treatment in AR Patients

> **NCT03640273** · PHASE2 · COMPLETED · sponsor: **Thammasat University** · enrollment: 72 (actual)

## Conditions studied

- Allergic Rhinitis
- Adverse Drug Event
- Quality of Life

## Interventions

- **DRUG:** Prapchompoothaweep remedy
- **DRUG:** Loratadine 10 Mg

## Key facts

- **NCT ID:** NCT03640273
- **Lead sponsor:** Thammasat University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-23
- **Primary completion:** 2018-01-04
- **Final completion:** 2018-06-24
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2018-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03640273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03640273, "Efficacy and Adverse Effects of Prapchompoothaweep Remedy and Loratadine for Treatment in AR Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03640273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*